Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penederm was a biopharmaceutical company dedicated to the development and commercialization of topical dermatological products. The company's portfolio was highlighted by Avita (tretinoin), a treatment for acne vulgaris, and Acticin (permethrin), used for the treatment of scabies. Penederm utilized proprietary drug delivery technologies to enhance the efficacy and safety profiles of established therapeutic agents. In 1998, the company was acquired by Mylan Laboratories to strengthen its presence in the branded dermatology market. Following the acquisition, its operations were integrated into Mylan's specialty pharmaceutical divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penederm.